Folgen
Marko Marjanovic
Marko Marjanovic
Bestätigte E-Mail-Adresse bei irb.hr
Titel
Zitiert von
Zitiert von
Jahr
The ATM signaling network in development and disease
TH Stracker, I Roig, PA Knobel, M Marjanovic
Frontiers in genetics 4, 45573, 2013
1822013
Novel cyano-and amidinobenzothiazole derivatives: synthesis, antitumor evaluation, and X-ray and quantitative structure− activity relationship (QSAR) analysis
I Caleta, M Kralj, M Marjanović, B Bertosa, S Tomić, G Pavlović, K Pavelić, ...
Journal of medicinal chemistry 52 (6), 1744-1756, 2009
1552009
Benzimidazole derivatives related to 2, 3-acrylonitriles, benzimidazo [1, 2-a] quinolines and fluorenes: synthesis, antitumor evaluation in vitro and crystal structure …
M Hranjec, G Pavlović, M Marjanović, M Kralj, G Karminski-Zamola
European journal of medicinal chemistry 45 (6), 2405-2417, 2010
1312010
CEP63 deficiency promotes p53-dependent microcephaly and reveals a role for the centrosome in meiotic recombination
M Marjanović, C Sánchez-Huertas, B Terré, R Gómez, JF Scheel, ...
Nature communications 6 (1), 7676, 2015
1172015
Cep63 and cep152 cooperate to ensure centriole duplication
NJ Brown, M Marjanović, J Lüders, TH Stracker, V Costanzo
PloS one 8 (7), e69986, 2013
1092013
GEMC 1 is a critical regulator of multiciliated cell differentiation
B Terré, G Piergiovanni, S Segura‐Bayona, G Gil‐Gómez, SA Youssef, ...
The EMBO journal 35 (9), 942-960, 2016
922016
Antitumor potential of crown ethers: structure− activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores
M Marjanović, M Kralj, F Supek, L Frkanec, I Piantanida, T Šmuc, ...
Journal of medicinal chemistry 50 (5), 1007-1018, 2007
772007
Synthesis and in vitro antitumor effect of diclofenac and fenoprofen thiolated and nonthiolated polyaspartamide-drug conjugates
M Barbarić, M Kralj, M Marjanović, I Husnjak, K Pavelić, J Filipović-Grčić, ...
European journal of medicinal chemistry 42 (1), 20-29, 2007
702007
A novel bis-phenanthridine triamine with pH controlled binding to nucleotides and nucleic acids
G Malojčić, I Piantanida, M Marinić, M Žinić, M Marjanović, M Kralj, ...
Organic & biomolecular chemistry 3 (24), 4373-4381, 2005
682005
The novel C-5 aryl, alkenyl, and alkynyl substituted uracil derivatives of L-ascorbic acid: synthesis, cytostatic, and antiviral activity evaluations
T Gazivoda, S Raić-Malić, M Marjanović, M Kralj, K Pavelić, J Balzarini, ...
Bioorganic & medicinal chemistry 15 (2), 749-758, 2007
672007
The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: Synthesis, cytostatic and antiviral activity evaluations
K Wittine, K Benci, Z Rajić, B Zorc, M Kralj, M Marjanović, K Pavelić, ...
European journal of medicinal chemistry 44 (1), 143-151, 2009
652009
Synthesis, antitumor evaluation and DNA binding studies of novel amidino-benzimidazolyl substituted derivatives of furyl-phenyl-and thienyl-phenyl-acrylates, naphthofurans and …
M Hranjec, K Starčević, I Piantanida, M Kralj, M Marjanović, M Hasani, ...
European journal of medicinal chemistry 43 (12), 2877-2890, 2008
502008
Functionally active toll‐like receptor 3 on human primary and metastatic cancer cells
T Matijevic, M Marjanovic, J Pavelic
Scandinavian journal of immunology 70 (1), 18-24, 2009
492009
Fenoprofen and ketoprofen amides as potential antitumor agents
M Marjanović, B Zorc, L Pejnović, M Zovko, M Kralj
Chemical Biology & Drug Design 69 (3), 222-226, 2007
492007
Guanidiniocarbonylpyrrole–Aryl Derivatives: Structure Tuning for Spectrophotometric Recognition of Specific DNA and RNA Sequences and for Antiproliferative Activity
L Hernandez‐Folgado, D Baretić, I Piantanida, M Marjanović, M Kralj, ...
Chemistry–A European Journal 16 (10), 3036-3056, 2010
482010
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns
F Supek, TŠ Ramljak, M Marjanović, M Buljubašić, G Kragol, N Ilić, ...
European journal of medicinal chemistry 46 (8), 3444-3454, 2011
402011
Guanidiniocarbonyl-pyrrole-aryl conjugates as nucleic acid sensors: Switch of binding mode and spectroscopic responses by introducing additional binding sites into the linker
K Gröger, D Baretić, I Piantanida, M Marjanović, M Kralj, M Grabar, ...
Organic & biomolecular chemistry 9 (1), 198-209, 2011
382011
Novel pentamidine derivatives: Synthesis, anti-tumor properties and polynucleotide-binding activities
I Jarak, M Marjanović, I Piantanida, M Kralj, G Karminski-Zamola
European journal of medicinal chemistry 46 (7), 2807-2815, 2011
372011
Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells
I Guberović, M Marjanović, M Mioč, K Ester, I Martin-Kleiner, ...
Scientific reports 8 (1), 14467, 2018
272018
Atypical cytostatic mechanism of N-1-sulfonylcytosine derivatives determined by in vitro screening and computational analysis
F Supek, M Kralj, M Marjanović, L Šuman, T Šmuc, I Krizmanić, B Žinić
Investigational new drugs 26, 97-110, 2008
272008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20